Antibody molecule-drug conjugates and uses thereof Grant US-11890319-B2 United States of America 06 Feb 2024
COMPOSITIONS AND METHODS FOR TRANSFERRIN RECEPTOR (TFR)-MEDIATED DELIVERY TO THE BRAIN… Application WO-2024026474-A1 World Intellectual Property Organisation (WIPO) 01 Feb 2024
ERIBULIN-BASED ANTIBODY-DRUG CONJUGATES AND METHODS OF USE Application US-20230398228-A1 United States of America 14 Dec 2023
Binding protein drug conjugates comprising anthracycline derivatives Grant US-11833120-B2 United States of America 05 Dec 2023
Compositions and methods related to anti-CD19 antibody drug conjugates Grant US-11827703-B2 United States of America 28 Nov 2023
Targeted compounds for the site-specific coupling of chemical moieties comprising a… Grant US-11813336-B2 United States of America 14 Nov 2023
Targeting tumor cells with chemotherapeutic agents conjugated to anti-matriptase… Grant US-11752215-B2 United States of America 12 Sep 2023
Antibody-drug conjugate comprising antibody against human ROR1 and use for the same Grant US-11707533-B2 United States of America 25 Jul 2023
METHODS OF TREATING SOLID TUMORS AND COMPOSITIONS THEREOF Application WO-2023133452-A1 World Intellectual Property Organisation (WIPO) 13 Jul 2023
Pyrrolobenzodiazepine dimer prodrug and ligand-linker conjugate compound of the same Grant US-11654197-B2 United States of America 23 May 2023
Conjugates comprising self-immolative groups and methods related thereto Grant US-11413353-B2 United States of America 16 Aug 2022
Nucleic acid synthesis and sequencing using tethered nucleoside triphosphates Application CN-114874337-A China 09 Aug 2022
C-TERMINAL LYSINE CONJUGATED IMMUNOGLOBULINS Application EP-4032902-A1 European Patent Office 27 Jul 2022
Anti-MSR1 antibodies and methods of use thereof Grant US-11377502-B2 United States of America 05 Jul 2022
Method of producing an immunoligand/payload conjugate Grant US-11364301-B2 United States of America 21 Jun 2022
Antibody-drug conjugates comprising branched linkers and methods related thereto Grant US-11173214-B2 United States of America 16 Nov 2021
Conjugates comprising peptide groups and methods related thereto Grant US-11167040-B2 United States of America 09 Nov 2021
ANTIBODY MOLECULE-DRUG CONJUGATES AND USES THEREOF Application US-20210316004-A1 United States of America 14 Oct 2021
C-terminal lysine conjugated immunoglobulins Grant US-11135304-B2 United States of America 05 Oct 2021
GLYCAN-INTERACTING COMPOUNDS AND METHODS OF USE Application EP-3589319-A4 European Patent Office 14 Jul 2021
Glycan-interacting compounds and methods of use Grant US-11028181-B2 United States of America 08 Jun 2021
Linkers for conjugation of cell-binding molecules Grant US-10975112-B2 United States of America 13 Apr 2021
Binding protein drug conjugates comprising anthracycline derivatives Grant US-10960083-B2 United States of America 30 Mar 2021
Cryptophycin compounds and conjugates, their preparation and their therapeutic use Grant US-10941139-B2 United States of America 09 Mar 2021
Method of producing an immunoligand/payload conjugate Grant US-10864277-B2 United States of America 15 Dec 2020
NOVEL CRYPTOPHYCIN COMPOUNDS AND CONJUGATES, THEIR PREPARATION AND THEIR THERAPEUTIC USE Application EA-035625-B1 Eurasian Patent Organisation 17 Jul 2020
Compounds, linker-drugs and ligand-drug conjugates Grant US-10683327-B2 United States of America 16 Jun 2020
Antibody-drug conjugate (ADC) and method for forming the same Grant US-10618935-B2 United States of America 14 Apr 2020
DRUG CONJUGATE COMPRISING QUINOLINE DERIVATIVES Application WO-2020058290-A1 World Intellectual Property Organisation (WIPO) 26 Mar 2020
ANTIBODY-DRUG CONJUGATE COMPRISING QUINOLINE DERIVATIVES Application FR-3085952-A1 France 20 Mar 2020
Binding protein drug conjugates comprising anthracycline derivatives Grant US-10517959-B2 United States of America 31 Dec 2019
RELEASABLE ANTIBODY CONJUGATES Application WO-2019171358-A1 World Intellectual Property Organisation (WIPO) 12 Sep 2019
Compounds comprising self-immolative group Application US-10383949-B2 United States of America 20 Aug 2019
Compounds, linker-drugs and ligand-drug conjugates Application US-10233212-B2 United States of America 19 Mar 2019
Binding protein drug conjugates comprising anthracycline derivatives Application US-10188745-B2 United States of America 29 Jan 2019
SERUM ALBUMIN BINDING AGENTS Application WO-2019016237-A1 World Intellectual Property Organisation (WIPO) 24 Jan 2019
Compositions and methods related to anti-CD19 antibody drug conjugates Application US-10183997-B2 United States of America 22 Jan 2019
Compositions and methods related to anti-EGFR antibody drug conjugates Application US-10118965-B2 United States of America 06 Nov 2018
METHOD FOR PREPARING ANTIBODY-DRUG CONJUGATE Application WO-2018177369-A1 World Intellectual Property Organisation (WIPO) 04 Oct 2018
CELL TARGETING CONJUGATES Application WO-2017213494-A1 World Intellectual Property Organisation (WIPO) 14 Dec 2017
C-TERMINAL LYSINE CONJUGATED IMMUNOGLOBULINS Application WO-2017106643-A1 World Intellectual Property Organisation (WIPO) 22 Jun 2017
NOVEL CRYPTOPHYCIN COMPOUNDS AND CONJUGATES, THEIR PREPARATION AND THEIR THERAPEUTIC USE Application WO-2017076998-A1 World Intellectual Property Organisation (WIPO) 11 May 2017
NOVEL LINKERS FOR CONJUGATION OF CELL-BINDING MOLECULES Application US-20150284416-A1 United States of America 08 Oct 2015